BTMD
biote Corp - Class A (BTMD)
Healthcare • NASDAQ • $2.18+4.31%
- Symbol
- BTMD
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Price
- $2.18
- Daily Change
- +4.31%
- Market Cap
- $81.24M
- Trailing P/E
- 5.07
- Forward P/E
- 3.82
- 52W High
- $4.75
- 52W Low
- $1.27
- Analyst Target
- $2.99
- Dividend Yield
- N/A
- Beta
- 1.71
biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and meet other administrative requirements; inventory management software to facilitate ordering and inventory control; an…
Company websiteResearch BTMD on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.